US FDA grants fast track designation to Evaxion Biotech’s personalised cancer therapy

Image: This fast-track designation will accelerate the regulatory body’s review of new drugs that showcase the potential to address an unmet medical requirement. Credit: Olga Kononenko on Unsplash.